Ondansetron Injection
Product Images NDC 71872-7107

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71872-7107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7107)

This text describes a medication called Ondansetron Injection, which is available for administration via IV or IM. It comes in a multiple dose vial containing 2 mg/mL of ondansetron and other compounds such as buffers, preservatives, and saline solution. It also provides information about the dosage and storage instructions. The medication is distributed by West-Ward Estown and the manufacturer's number is also provided.*

FDA Label Image

Structural Formula (Ondansetron Injection 1)

FDA Label Image

Ndc 0143-9890-01 Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 20 mL Multiple Dose Vial Each 1 mL Of Aqueous Solution In The 20 mL Multidose Vial Contains 2 mg Of O (Ondansetron Injection 3)

This is a description of a medication called Ondansetron available in an injectable form. It has a strength of 40 mg/20 mL with 2 mg/mL concentration and is suitable for intravenous or intramuscular use. The medication is sterile and has sodium chloride USP, water, and some other components. Dosage instructions are mentioned on the package, and the manufacturer is Hixma Armaceutica Portugall S.A., distributed in the USA by Westaward Pharmaceutical Corp, Evortoun, N2. Lot number and expiry date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.